 |
|
|
|
|
|
|
|
 |
Results for 'Cell Therapy Commercialization' |
|
|
| Title |
 |
Publication Date |
|
Price |
|
Relevance |
 |
|
|
|
|
Pipeline Insight: Therapeutic Cancer Vaccines
A turbulent path from bench to bedside
|
December 2006 |
£6000 |
35 % |
Stakeholder Opinions
Novel Therapeutic Approaches in Cardiovascular Medicine - Lack of Market Prospects for Biologics Expose An Opportunity for Cell and Gene Therapies
|
July 2008 |
£3800 |
35 % |
Cancer Cell Therapy Markets
|
March 2008 |
£1690 |
30.8 % |
Cell Therapy Markets
|
July 2007 |
£1690 |
27.65 % |
Pipeline Insight: Innovative Therapies
Targeted therapy, a clinical and commercial revolution?
|
August 2004 |
£6000 |
26.6 % |
Pipeline Insight: Cancer Vaccines and Cell Therapies
Technical Know How Needs Translation Into Clinical and Commercial Rewards
|
April 2005 |
£6000 |
26.25 % |
Optimizing Targeted Treatment in Cancer
Negotiating the Challenges to Success
|
September 2005 |
£1000 |
25.9 % |
Stakeholder Opinions: Acute Leukemias
Persistent unmet needs confer significant commercial opportunity
|
April 2006 |
£2170 |
23.8 % |
Poniard Pharmaceuticals Inc
Premium Company Profile
|
April 2008 |
£265 |
23 % |
Triple Analysis: Melanoma Therapeutics, Antibodies and Vaccines in Oncology
|
August 2006 |
£2340 |
21 % |
Cancer Personalized Medicine 2008
|
July 2008 |
£2425 |
19.6 % |
Triple Analysis: Apoptosis Agents, Antibodies and Vaccines in Oncology
|
December 2006 |
£2340 |
18.2 % |
Pipeline Insight: Non-Small Cell Lung Cancer
Pipeline set to offer only modest improvements
|
April 2008 |
£6000 |
18.2 % |
Cell Therapy
Technologies, Markets and Companies
|
September 2008 |
£2410 |
17.5 % |
Pipeline/Commercial Insight: Innovative Targeted Therapies
Smart Drugs' on Target for Increasing Growth
|
October 2005 |
£8695 |
17.15 % |
Stakeholder Opinions: Systemic Lupus Erythematosus
Market Set to Enter Era of Biologic Therapies
|
March 2008 |
£2000 |
15.75 % |
Targeted Therapies in Oncology
A World Review
|
December 2006 |
£3360 |
15.05 % |
Pipeline/Commercial Insight: Molecular Targeted Cancer Therapies
More drugs on the market, more targets in the pipeline
|
October 2006 |
£8000 |
14.7 % |
Cancer Biomarkers
Enhancing diagnostic, therapeutic and developmental strategies
|
May 2006 |
£2195 |
14.7 % |
Companion Diagnostics in Personalized Medicine and Cancer Therapy
|
April 2008 |
£1715 |
14.35 % |
Pipeline Insight: Upper GI Disorders - Generics will limit pipeline profit
|
July 2007 |
£6000 |
11.55 % |
Pharmacogenomics: New Technologies
In the Development of Personalized Therapies
|
August 2005 |
£2255 |
11.2 % |
Blood
The Worldwide Market for Blood Products, Blood Testing, Blood Equipment, and Synthetic Blood Products
|
September 2006 |
£1970 |
9.8 % |
United States Drug Delivery Devices Medical Equipment Industry Report
Detailed Analysis of the Medical Equipment & Medical Devices Market Covering Infusion Systems, Inhalation Systems and Needle Free Injections Medical Equipment and Supplies
|
April 2008 |
£1515 |
9.45 % |
Medical Device Development
A Regulatory Overview 2000
|
December 2000 |
£85 |
8.75 % |
Molecular Diagnostics
Technologies, Markets and Companies
|
September 2008 |
£2410 |
8.4 % |
Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
8.05 % |
Italy Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
8.05 % |
Japan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7.7 % |
UK Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7.7 % |
China Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7.35 % |
Brazil Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7.35 % |
South Africa Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7.35 % |
Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7.35 % |
Australia Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
7 % |
Italy Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
6.65 % |
UK Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
6.65 % |
Brazil Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
6.3 % |
South Africa Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
6.3 % |
Japan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
6.3 % |
Australia Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
5.95 % |
Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2012
|
May 2008 |
£1515 |
5.95 % |
|
|
|
|
